We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+17.29%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.22B
AUM Growth
-$65.3M
Cap. Flow
-$208M
Cap. Flow %
-16.99%
Top 10 Hldgs %
34.8%
Holding
287
New
134
Increased
23
Reduced
46
Closed
28

Top Buys

Rank Stock Value
1
BWA icon
BorgWarner
BWA
+$20.6M
2
HGV icon
Hilton Grand Vacations
HGV
+$19M
3
CVNA icon
Carvana
CVNA
+$12.5M
4
NATL icon
NCR Atleos
NATL
+$9.39M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$6.39M

Top Sells

Rank Stock Value
1
ENVA icon
Enova International
ENVA
+$28.6M
2
FLG
Flagstar Bank National Association
FLG
+$24.5M
3
VST icon
Vistra
VST
+$18.3M
4
NE icon
Noble Corp
NE
+$16.1M
5
PHIN icon
Phinia Inc
PHIN
+$8.72M

Sector Composition

Rank Sector Weight
1 Healthcare 23.14%
2 Consumer Discretionary 18.74%
3 Financials 10.52%
4 Materials 4.8%
5 Industrials 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTHX
201
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$194K 0.02%
+63,765
New +$120K
LAB icon
202
Standard BioTools
LAB
$307M
$193K 0.02%
+87,189
New +$186K
REAL icon
203
The RealReal
REAL
$1.52B
$190K 0.02%
+94,652
New +$184K
AQST icon
204
Aquestive Therapeutics
AQST
$471M
$189K 0.02%
+93,510
New +$165K
GALT icon
205
Galectin Therapeutics
GALT
$203M
$184K 0.02%
+111,035
New +$215K
CIA icon
206
Citizens
CIA
$235M
$174K 0.01%
+64,659
New +$200K
HRTG icon
207
Heritage Insurance Holdings
HRTG
$915M
$158K 0.01%
+24,250
New +$167K
GCTS.WS
208
GCT Semiconductor Holding Warrants
GCTS.WS
$17.9M
$150K 0.01%
1,503,100
– –
TKNO icon
209
Alpha Teknova
TKNO
$301M
$150K 0.01%
+40,092
New +$98.8K
BLUE
210
DELISTED
bluebird bio
BLUE
$138K 0.01%
+5,000
New +$305K
KLRS
211
Kalaris Therapeutics
KLRS
$99.7M
$130K 0.01%
+8,286
New +$327K
CNDA.WS
212
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$107K 0.01%
825,000
– –
REPL icon
213
Replimune Group
REPL
$994M
$93K 0.01%
+11,027
New +$128K
COGT icon
214
Cogent Biosciences
COGT
$7.22B
$92.3K 0.01%
+15,694
New +$120K
TGTX icon
215
CALL
TG Therapeutics
TGTX
$7.64B
$85.4K 0.01%
+5,000
New +$58.1K
PNST.WS
216
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$83K 0.01%
225,000
– –
AMC icon
217
PUT
AMC Entertainment Holdings
AMC
$2.38B
$67.3K 0.01%
11,000
-89,000
-89% -$722K
AMC icon
218
AMC Entertainment Holdings
AMC
$2.38B
$66.1K 0.01%
10,800
-200
-2% -$1.62K
NNBR icon
219
NN Inc
NNBR
$301M
$64K 0.01%
+15,993
New +$38K
BHACW
220
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$59.4K ﹤0.01%
990,000
– –
NUVB.WS
221
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$50.1K ﹤0.01%
835,323
– –
CBIO
222
Crescent Biopharma
CBIO
$586M
$45.7K ﹤0.01%
+194
New +$30.2K
CRGOW icon
223
Freightos Ltd Warrant
CRGOW
$1.99M
$44K ﹤0.01%
440,000
-10,000
-2% -$677
CLDI.WS
224
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$30K ﹤0.01%
600,000
– –
TCOA.WS
225
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$29.5K ﹤0.01%
742,500
– –
7 8
9
10 11

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, 683 Capital Management held 287 positions worth $1.22B, down 5.1% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

683 Capital Management withdrew a net $208M in Q4 2023, closing 28 positions and reducing 46 holdings. Its most notable exit was Hess, an estimated $7.65M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in NCR Atleos worth $9.96M.

  • 683 Capital Management's largest Q4 2023 buy was NCR Atleos: 410,000 shares worth $9.96M.
  • 683 Capital Management added most to BorgWarner in Q4 2023, an estimated $20.6M increase.
  • 683 Capital Management's biggest Q4 2023 reduction was Enova International, cutting an estimated $28.6M.
  • 683 Capital Management fully exited Hess in Q4 2023, selling an estimated $7.65M.
  • 683 Capital Management's ten largest holdings make up 35% of its $1.22B portfolio in Q4 2023.
  • 683 Capital Management opened 134 new positions and closed 28 in Q4 2023.
  • 683 Capital Management's portfolio value fell 5.1% quarter-over-quarter to $1.22B.

Based on 683 Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.